| (210) | Number of the EPO application | 18816468 |
| (220) | Filing date of the EPO application | 2018.11.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2024, 2024.11.20 |
| (110) | EPO patent number | 3717455 |
| (21) | Number of the application | e 2020 1005 |
| (71) | Name(s) of applicant(s), code of the country | VERTEX PHARMACEUTICALS INCORPORATED, US; |
| (72) | Name(s) of inventor(s), code of the country | LEMERCIER LEWANDOWSKI Berenice, US;
LEWIS Robert, US;
LOOKER Adam, US;
MORGAN Adam, US;
ROEPER Stefanie, US;
RYAN Michael, US;
SOLSONA ROCABERT Juan Gabriel, ES;
WILDE Nathan, US; |
| (73) | Name(s) of owner(s), code of the country | VERTEX PHARMACEUTICALS INCORPORATED, US; |
| (54) | Title of the invention | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 215/56 (2006.01.01); C07C 69/96 (2006.01.01); C07B 59/00 (2006.01.01); C07C 33/18 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.10.31 |
| (30) | Priority | 17382829, 2017.12.01, EP |
| (86) | International application | PCT/US2018/063451, 2018.11.30 |
| (87) | International publication | WO 2019/109021, 2019.06.06 |